SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-003792
Filing Date
2024-11-21
Accepted
2024-11-21 06:50:23
Documents
14
Period of Report
2024-11-21

Document Format Files

Seq Description Document Type Size
1 6-K zk2432369.htm 6-K 41082
2 OPINION OF FISCHER (FBC & CO.) exhibit_5-1.htm EX-5.1 10991
3 OPINION OF GREENBERG TRAURIG, P.A. exhibit_5-2.htm EX-5.2 15370
4 LICENSE AGREEMENT exhibit_10-1.htm EX-10.1 333092
5 FIRST AMENDMENT DATED AS OF NOVEMBER 14, 2024 exhibit_10-2.htm EX-10.2 75802
6 SECURITIES PURCHASE AGREEMENT DATED AS OF NOVEMBER 20, 2024 exhibit_10-3.htm EX-10.3 195191
7 FORM OF PRE-FUNDED WARRANT exhibit_10-4.htm EX-10.4 83655
8 FORM OF ORDINARY WARRANT exhibit_10-5.htm EX-10.5 89170
9 PRESS RELEASE, DATED NOVEMBER 21, 2024 exhibit_99-1.htm EX-99.1 24309
10 image0.jpg GRAPHIC 24783
11 image1.jpg GRAPHIC 9227
12 image00002.jpg GRAPHIC 9117
13 image00003.jpg GRAPHIC 7570
14 image00005.jpg GRAPHIC 3397
  Complete submission text file 0001178913-24-003792.txt   944885
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 241482153
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)